Oral iron therapy for heart failure with reduced ejection fraction

Circulation: Heart Failure

Volumn 9, Issue 5, 2016, Pages

  Lewis, Gregory D ^a   Semigran, Marc J ^a   Givertz, Michael M ^b   Malhotra, Rajeev ^a   Anstrom, Kevin J ^c   Hernandez, Adrian F ^d   Shah, Monica R ^b   Braunwald, Eugene ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

clinical trial; exercise; heart failure; iron; oxygen consumption

Indexed keywords

IRON POLYSACCHARIDE; PLACEBO; ANTIANEMIC AGENT; BIOLOGICAL MARKER; IRON DERIVATIVE; OXYGEN; POLYSACCHARIDE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEART EJECTION FRACTION; HEART FAILURE; HOMEOSTASIS; HUMAN; IRON DEFICIENCY; IRON THERAPY; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; ANEMIA, IRON-DEFICIENCY; BLOOD; CARDIAC MUSCLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONVALESCENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EXERCISE TOLERANCE; METABOLISM; METHODOLOGY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; HEART FAILURE; HEMATINICS; HUMANS; IRON COMPOUNDS; MYOCARDIUM; OXYGEN; OXYGEN CONSUMPTION; POLYSACCHARIDES; RECOVERY OF FUNCTION; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84969188133     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.000345     Document Type: Article

References (58)

1. O'Neill JO, Young JB, Pothier CE, Lauer MS, Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 2005 111 2313 2318. doi: 10.1161/01.CIR.0000164270.72123.18
2. Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, Coats AJ, Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 2000 21 154 161. doi: 10.1053/euhj.1999.1863
3. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J, Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985 55 1037 1042
4. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, Forman D, Franklin B, Guazzi M, Gulati M, Keteyian SJ, Lavie CJ, Macko R, Mancini D, Milani RV, American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010 122 191 225. doi: 10.1161/CIR.0b013e3181e52e69
5. Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, Collins E, Fletcher G, American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 2007 116 329 343. doi: 10.1161/CIRCULATIONAHA.106.184461
6. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP, Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002 288 2144 2150
7. Corrà U, Piepoli MF, Adamopoulos S, Agostoni P, Coats AJ, Conraads V, Lambrinou E, Pieske B, Piotrowicz E, Schmid JP, Seferović PM, Anker SD, Filippatos G, Ponikowski PP, Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC. Eur J Heart Fail 2014 16 929 941. doi: 10.1002/ejhf.156
8. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J, European Association for Cardiovascular Prevention & Rehabilitation; American Heart Association EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012 126 2261 2274. doi: 10.1161/CIR.0b013e31826fb946
9. Clark AL, Poole-Wilson PA, Coats AJ, Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996 28 1092 1102. doi: 10.1016/S0735-1097(96)00323-3
10. Piña IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ, American Heart Association Committee on exercise, rehabilitation, and prevention Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003 107 1210 1225
11. Massie BM, Conway M, Rajagopalan B, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 1988 78 320 326
12. Drexler H, Faude F, Höing S, Just H, Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone. Circulation 1987 76 1344 1352
13. Sullivan MJ, Green HJ, Cobb FR, Skeletal muscle biochemistry and histology in ambulatory patients with long-Term heart failure. Circulation 1990 81 518 527
14. Bennett FM, A role for neural pathways in exercise hyperpnea. J Appl Physiol Respir Environ Exerc Physiol 1984 56 1559 1564
15. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, Coats AJ, Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997 30 1758 1764
16. Dallman PR, Iron deficiency: does it matter? J Intern Med 1989 226 367 372
17. Weiss G, Goodnough LT, Anemia of chronic disease. N Engl J Med 2005 352 1011 1023. doi: 10.1056/NEJMra041809
18. Dunn LL, Suryo Rahmanto Y, Richardson DR, Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007 17 93 100. doi: 10.1016/j.tcb.2006.12.003
19. Davies KJ, Maguire JJ, Brooks GA, Dallman PR, Packer L, Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion. Am J Physiol 1982 242 E418 E427
20. Petering DH, Stemmer KL, Lyman S, Krezoski S, Petering HG, Iron deficiency in growing male rats: a cause of development of cardiomyopathy. Ann Nutr Metab 1990 34 232 243
21. Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J, Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond) 2005 109 277 286. doi: 10.1042/CS20040278
22. Toblli JE, Lombraña A, Duarte P, Di Gennaro F, Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007 50 1657 1665. doi: 10.1016/j.jacc.2007.07.029
23. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Mori C, von Eisenhart Rothe B, Pocock S, Poole-Wilson PA, Ponikowski P, FAIR-HF committees and investigators Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail 2009 11 1084 1091. doi: 10.1093/eurjhf/hfp140
24. Maguire JJ, Davies KJ, Dallman PR, Packer L, Effects of dietary iron deficiency of iron-sulfur proteins and bioenergetic functions of skeletal muscle mitochondria. Biochim Biophys Acta 1982 679 210 220
25. Haas JD, Brownlie T IV., Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001 131 2S-2 676S 688S; discussion 688S
26. Davies KJ, Donovan CM, Refino CJ, Brooks GA, Packer L, Dallman PR, Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. Am J Physiol 1984 246 6 pt 1 E535 E543
27. Ohira Y, Edgerton VR, Gardner GW, Senewiratne B, Barnard RJ, Simpson DR, Work capacity, heart rate and blood lactate responses to iron treatment. Br J Haematol 1979 41 365 372
28. Herbert V, Recommended dietary intakes (RDI) of iron in humans. Am J Clin Nutr 1987 45 679 686
29. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI, Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006 48 2485 2489. doi: 10.1016/j.jacc.2006.08.034
30. Weiss G, Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009 1790 682 693. doi: 10.1016/j.bbagen.2008.08.006
31. Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Oleśkowska-Florek W, Zymliński R, Biegus J, Siwołowski P, Banasiak W, Anker SD, Filippatos G, Cleland JG, Ponikowski P, Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 2014 35 2468 2476. doi: 10.1093/eurheartj/ehu235
32. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA, Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013 165 575 582.e3. doi: 10.1016/j.ahj.2013.01.017
33. Cohen-Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, Zannad F, Laperche T, Leclercq C, Concas V, Duvillié L, Darné B, Anker S, Mebazaa A, High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 2014 16 984 991. doi: 10.1002/ejhf.139
34. Enjuanes C, Klip IT, Bruguera J, Cladellas M, Ponikowski P, Banasiak W, van Veldhuisen DJ, van der Meer P, Jankowska EA, Comín-Colet J, Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol 2014 174 268 275. doi: 10.1016/j.ijcard.2014.03.169
35. Maeder MT, Khammy O, dos Remedios C, Kaye DM, Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 2011 58 474 480. doi: 10.1016/j.jacc.2011.01.059
36. Georgieva Z, Georgieva M, Compensatory and adaptive changes in microcirculation and left ventricular function of patients with chronic iron-deficiency anaemia. Clin Hemorheol Microcirc 1997 17 21 30
37. Jankowska EA, Ponikowski P, Molecular changes in myocardium in the course of anemia or iron deficiency. Heart Fail Clin 2010 6 295 304. doi: 10.1016/j.hfc.2010.03.003
38. Nagao M, Matsuo Y, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, Abe K, Mukai Y, Higo T, Yabuuchi H, Takemura A, Yoshiura T, Sunagawa K, Honda H, Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2∗ magnetic resonance imaging. Am J Cardiol 2014 113 1024 1030. doi: 10.1016/j.amjcard.2013.11.061
39. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM, Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006 48 1225 1227. doi: 10.1016/j.jacc.2006.07.015
40. Usmanov RI, Zueva EB, Silverberg DS, Shaked M, Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 2008 21 236 242
41. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P, Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008 51 103 112. doi: 10.1016/j.jacc.2007.09.036
42. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009 361 2436 2448. doi: 10.1056/NEJMoa0908355
43. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD, CONFIRM-HF Investigators Beneficial effects of long-Term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J 2015 36 657 668. doi: 10.1093/eurheartj/ehu385
44. Avni T, Leibovici L, Gafter-Gvili A, Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-Analysis. Eur J Heart Fail 2012 14 423 429. doi: 10.1093/eurjhf/hfs017
45. Kapoor M, Schleinitz MD, Gemignani A, Wu WC, Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-Analysis. Cardiovasc Hematol Disord Drug Targets 2013 13 35 44
46. Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A, Tissue Doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy. Echocardiography 2012 29 13 18. doi: 10.1111/j.1540-8175.2011.01532.x
47. Motoki H, Borowski AG, Shrestha K, Troughton RW, Tang WH, Thomas JD, Klein AL, Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. J Am Coll Cardiol 2012 60 2074 2081. doi: 10.1016/j.jacc.2012.07.047
48. Bertini M, Ng AC, Antoni ML, Nucifora G, Ewe SH, Auger D, Marsan NA, Schalij MJ, Bax JJ, Delgado V, Global longitudinal strain predicts long-Term survival in patients with chronic ischemic cardiomyopathy. Circ Cardiovasc Imaging 2012 5 383 391. doi: 10.1161/CIRCIMAGING.111.970434
49. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ, RED-HF Committees; RED-HF Investigators Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013 368 1210 1219. doi: 10.1056/NEJMoa1214865
50. Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N, Iron-hf study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol 2013 168 3439 3442
51. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A, Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007 110 2 pt 1 267 278. doi: 10.1097/01.AOG.0000275286.03283.18
52. Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA, Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol 2011 151 307 312. doi: 10.1016/j.ijcard.2010.05.066
53. Bailie GR, Comparison of rates of reported adverse events associated with i.v. iron products in the United States. Am J Health Syst Pharm 2012 69 310 320. doi: 10.2146/ajhp110262
54. Niehaus ED, Malhotra R, Cocca-Spofford D, Semigran M, Lewis GD, Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure. J Card Fail 2015 21 694 697. doi: 10.1016/j.cardfail.2015.05.006
55. Coe EM, Bowen LH, Speer JA, Bereman RD, Comparison of polysaccharide iron complexes used as iron supplements. J Inorg Biochem 1995 57 287 292
56. Ganzoni AM, [Intravenous iron-dextran: therapeutic and experimental possibilities]. Schweiz Med Wochenschr 1970 100 301 303
57. Guazzi M, Dickstein K, Vicenzi M, Arena R, Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail 2009 2 549 555. doi: 10.1161/CIRCHEARTFAILURE.109.881326
58. Chatterjee NA, Murphy RM, Malhotra R, Dhakal BP, Baggish AL, Pappagianopoulos PP, Hough SS, Semigran MJ, Lewis GD, Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular function. Circ Heart Fail 2013 6 499 507. doi: 10.1161/CIRCHEARTFAILURE.112.000157